It makes sense to me I am afraid.Miller is happy to carry on as is and prefers to be the head of a small business, rather than play a bit part in a much larger one.
Even if she did she isn't capable of making it happen.
If nothing changes in the near term I will not be voting for her re-election and suggest those similarly frustrated do the same.
A shake up of the BOD's I believe is the only way Biotron can move forward but I would love to be proved wrong.
Ann: POSITIVE FDA GUIDANCE FOR COVID-19 CLINICAL PROGRAM, page-470
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
